Identifying Breast Cancer Targets Using NGS

Customer Interview

Identifying Breast Cancer Targets Using NGS

The Breast Cancer Atlas Project is sequencing more than a million breast cancer cells with the NovaSeq 6000 System.

Read Article
Using Analytics to Improve Cancer Diagnosis

Customer Interview

Using Analytics to Improve Cancer Diagnosis

Developing and automating workflows for analyzing, processing, and sharing genomic data among researchers and clinicians.

Read Article
Transforming Oncology with Genomics

Customer Video

Transforming Oncology with Genomics

Researchers from the Ontario Institute for Cancer Research and United Health Network share how knowing more about cancer biology through genomic...

View Video
See More Interviews See More Videos
 

Core Technology

Sequencing

See what sequencing can do for you

Learn MoreCompare Sequencers
 

Core Technology

Microarrays

Analyze genetic variation on any scale

Learn MoreCompare Array Scanners
See All Instruments
 

Announcing Illumina Complete Long Reads

Illumina Complete Long Read technology enables both long and short reads on the same NovaSeq instrument.

Learn More

Dream big. NovaSeq X can make it happen.

Learn More

Limited Time Offer on Ribo-Zero Plus Kit

Save on the Ribo-Zero Plus Microbiome rRNA Depletion Kit, restrictions apply.

Order Now

Training and Webinars

Illumina offers webinars and free online training courses to get the most out of your experiments and products

View Webinars View Courses
 

Featured Tool

TruSight Oncology 500 Selection Tool

Filter by batch size, system, software, and more. Compare and cart products.

Find the Right Kit

Popular Tools

See More Tools

Featured News

CGP validated in triple-negative breast cancer patients

Taiwanese study shows 500-gene panel detects actionable mutations and other critical biomarkers to open doors to advanced treatments

Read Article
Date Publication Title
25 Apr 2023 ITVX Blood test for lung cancer could speed up diagnosis in Wales as trial launched
11 Apr 2023 Inside Precision Medicine Illumina, Henry Ford Health Partner to Study Impact of CGP on Cardiovascular Disease
31 Mar 2023 HealthAffairs Thinking Differently About Multicancer Early Detection Screening Tests

View All Illumina News

 
Employee Story

Follow Suzanne through her typical day as a Bioinformatics Scientist

View Video View More Stories
Search Jobs

Follow Suzanne through her typical day as a Bioinformatics Scientist

For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2023 Illumina, Inc. All rights reserved.